Statistics

Total Visits

Views
EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER49

Select a period of time:

Number of views in the range

Views
EFFICACY AND SAFETY OF CARBOPLATIN AND PEMETREXED FOR THE FIRST LINE TREATMENT OF UNFIT PATIENTS TO RECEIVE CISPLATIN WITH NONSQUAMOUS NON SMALL CELL LUNG CANCER28

Views

Views
January 20258
February 20250
March 202516
April 20251
May 20251
June 20251
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States7
United Kingdom2
Chile2
Spain1
 

Top cities views

Views
London2
Los Angeles2
Santiago Metropolitan2
Alexandria2
Boston1
Buffalo1
Miami1